A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
American Society of Clinical Oncology
Eli Lilly and Company
Dana-Farber Cancer Institute
AstraZeneca
NiKang Therapeutics, Inc.
AstraZeneca
UNC Lineberger Comprehensive Cancer Center